ETF STRATEGIES

Improve Your ETF Trading

ETF PowerRatings: New ETF Strategies for the ETF Market

If you've been looking for a way to get into the ETF market, then ETF PowerRatings may be the most important trading resource you access this year.

Lock in the Gains: ETF Trading Strategies for Short Term Traders

Learn How to Trade ETF Funds Successfully: TPS and the Science of Scaling-In

Moving Averages: ETF Strategies for Short Term Traders

Receive Alerts

Free

For One Week!

Stock PowerRatings

Use PowerRatings every day to find the stocks for tomorrow to focus on and the ones to avoid. Sign Up Now >>

ETF PowerRatings

Use PowerRatings to find the ETFS to focus on to build your portfolio for ETF gains.
Sign Up Now >>

Gary Kaltbaum Intraday Breaking Setups

Let Gary Kaltbaum send you timely emails to alert you when breakouts occur.
Sign Up Now >>

Kevin Haggerty's Professional Trading Service

Every day receive the best plan of attack for the next day's trading directly from professional trader Kevin Haggerty.
Sign Up Now >>

TradingMarkets AS SEEN ON...

Yahoo! Finance (content partner)
Forbes.com (content partner)
AOL Money (content partner)
CNBC
Fox Business News
Bloomberg TV
Wall Street Journal
MarketWatch
Fortune
New York Times
Stocks and Commodities
Active Trader Magazine
Los Angeles Times
Futures Magazine
Barrons
Reuters
SFO Magazine
Investor's Edge
E*Trade Radio
Bloomberg Markets Magazine
Chicago Mercantile Exchange
Forbes.com
SFO
Registered Rep
FXstreet.com

Results matching symbol: ARQL

SmarTrend's Candlestick Scanner Detects Bearish Engulfing Pattern for Arqule (ARQL)

March 16, 2010

Mar 16, 2010 (SmarTrend(R) Market Surveillance via COMTEX) --

SmarTrend's candlestick pattern scanner has detected a bearish engulfing pattern for shares of Arqule (NASDAQ:ARQL) since the stock clo Read More >>

BiomedReports: News and FDA Updates for ArQule (Nasdaq:ARQL), BioMimetic (NASDAQ:BMTI), BioSante (NASDAQ:BPAX)

March 05, 2010

Pasadena, CA, Mar 05, 2010 (M2 PRESSWIRE via COMTEX) --

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a commu Read More >>

ArQule Posts Fiscal 2009 4Q and Year End Results

March 05, 2010

Mar 05, 2010 (Close-Up Media via COMTEX) --

ArQule, Inc. has announced its financial results for the year and for the fourth quarter ended December 31, 2009.

In a release on March 2, the Co Read More >>

ArQule, Inc. to Present at Cowen and Company Health Care Conference

March 04, 2010

WOBURN, Mass., Mar 04, 2010 (BUSINESS WIRE) --

ArQule, Inc. (Nasdaq: ARQL) today announced that the Company will present at the Cowen and Company 30th Annual Health Care Conference Read More >>

ArQule Inc (ARQL) Corporate Event Announcement Notice

March 03, 2010

Mar 03, 2010 (Wall Street Horizon via COMTEX) --

ArQule Inc (ARQL)

Expected next earnings release:

Announcement date: 5/6/2010 - Before Market

Earnings Quarter: Q1

Announcement Sta
          
            Read More
            >>

ArQule Inc (ARQL) Corporate Event Announcement Notice

March 02, 2010

Mar 02, 2010 (Wall Street Horizon via COMTEX) --

ArQule Inc (ARQL)

Expected next earnings release:

Announcement date: 3/2/2010 - Before Market

Earnings Quarter: Q4

Announcement Sta
          
            Read More
            >>

ArQule Guides Revenue Below Estimates; but Sees a Smaller-than-expected Loss

March 02, 2010

Mar 02, 2010 (EarningsWhispers Guidance Summaries via Comtex) --

ArQule Inc. (NASDAQ: ARQL) said it expects a 2010 loss of $0.84 to $0.76 per share on revenue of $24.0 million to $28.0 million. The Read More >>

ArQule Reports Fiscal 2009 Year End and Fourth Quarter Results

March 02, 2010

WOBURN, Mass., Mar 02, 2010 (BUSINESS WIRE) --

ArQule, Inc. (NASDAQ: ARQL) today announced its financial results for the year and for the fourth quarter ended December 31, 2009.

The Read More >>

ArQule Inc (ARQL) Corporate Event Announcement Notice

March 01, 2010

Mar 01, 2010 (Wall Street Horizon via COMTEX) --

ArQule Inc (ARQL)

Expected next earnings release:

Announcement date: 3/2/2010 - Before Market

Earnings Quarter: Q4

Announcement Sta
          
            Read More
            >>

ArQule Inc (ARQL) Corporate Event Announcement Notice

February 24, 2010

Feb 24, 2010 (Wall Street Horizon via COMTEX) --

ArQule Inc (ARQL)

Expected next earnings release:

Announcement date: 3/2/2010 - Before Market

Earnings Quarter: Q4

Announcement Sta
          
            Read More
            >>

BiomedReports: News and FDA Updates for AmStem (OTC:AMST), ArQule (NASDAQ:ARQL), Baxter (NYSE:BAX)

February 24, 2010

Pasadena, CA, Feb 24, 2010 (M2 PRESSWIRE via COMTEX) --

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a commu Read More >>

ArQule Inc (ARQL) Corporate Event Announcement Notice

February 23, 2010

Feb 23, 2010 (Wall Street Horizon via COMTEX) --

ArQule Inc (ARQL)

Expected next earnings release:

Announcement date: 3/2/2010 - Before Market

Earnings Quarter: Q4

Announcement Sta
          
            Read More
            >>

ArQule to Report Fiscal 2009 Financial Results on March 2, 2010

February 23, 2010

WOBURN, Mass., Feb 23, 2010 (BUSINESS WIRE) --

ArQule, Inc. (NASDAQ: ARQL) today announced that it will report its financial results for the fiscal 2009 year-end and fourth quarter on Read More >>

ArQule Inc (ARQL) Corporate Event Announcement Notice

February 22, 2010

Feb 22, 2010 (Wall Street Horizon via COMTEX) --

ArQule Inc (ARQL)

Expected next earnings release:

Announcement date: 3/4/2010 - Before Market

Earnings Quarter: Q4

Announcement Sta
          
            Read More
            >>

ArQule Inc (ARQL) Corporate Event Announcement Notice

February 12, 2010

Feb 12, 2010 (Wall Street Horizon via COMTEX) --

ArQule Inc (ARQL)

Expected next earnings release:

Announcement date: 3/4/2010 - Before Market

Earnings Quarter: Q4

Announcement Sta
          
            Read More
            >>

ArQule Inc (ARQL) Corporate Event Announcement Notice

February 11, 2010

Feb 11, 2010 (Wall Street Horizon via COMTEX) --

ArQule Inc (ARQL)

Expected next earnings release:

Announcement date: 3/4/2010 - Before Market

Earnings Quarter: Q4

Announcement Sta
          
            Read More
            >>

SmarTrend Detects Continued Selling Pressure in Shares of Arqule (ARQL)

February 05, 2010

Feb 05, 2010 (SmarTrend(R) Spotlight via COMTEX) --

SmarTrend identified a Downtrend for Arqule (NASDAQ:ARQL) on January 22, 2010 at $3.30. In approximately 2 weeks, Arqule has returned 7.6% as of Read More >>

Fastmoneytalk.com: Smokefree Innotec to start deliveries to European casinos & ArQule Announces Initiation of Clinical Progr

February 04, 2010

Boston, MA, Feb 04, 2010 (M2 PRESSWIRE via COMTEX) --

Smokefree Innotec, Inc. (PINKSHEETS: SFIO); ArQule, Inc. (Nasdaq: ARQL)

FastMoneyTalk.com is part of Stock Profiler.US, LLC's News Divi Read More >>

ArQule Announces Initiation of Clinical Programs with ARQ 197 in Germ Cell Tumors and Colorectal Cancer

February 04, 2010

WOBURN, Mass., Feb 04, 2010 (BUSINESS WIRE) --

ArQule, Inc. (Nasdaq: ARQL) today announced the initiation of a Phase 2, single agent trial with ARQ 197 in germ cell tumors (GCT), including Read More >>

Downtrend Spotted in Shares of Arqule (ARQL)

January 28, 2010

Jan 28, 2010 (SmarTrend(R) Spotlight via COMTEX) --

SmarTrend identified a Downtrend for Arqule (NASDAQ:ARQL) on January 22, 2010 at $3.30. In approximately 1 week, Arqule has returned 3% as of Thu Read More >>

Dow Edges Closer to 13,000 Mark

December 29, 2009

Major blue chip movers in the Dow included IBM and Honeywell with gains of over 3%. Read More >>

And So It Goes

December 29, 2009

More disassembling of the growth sector. Read More >>

Which Gap Is It?

December 29, 2009

All gaps are not the same. Some are prone to failure, while others signify Read More >>

Arqule Up 7.6% Since SmarTrend's Buy Recommendation

December 29, 2009

Dec 15, 2009 (SmarTrend(R) Spotlight via COMTEX) -- ARQL | Quote | Chart | News | PowerRating -- SmarTrend, our proprietary pattern recognition system, called an Uptrend for Arqule (NASDAQ:ARQL) on December 02, 2009 at $3.73.Since then, Arqule has returned 7.6% as of todays recent price of $ Read More >>

Arqule Down 35.1% Since SmarTrend's Sell Recommendation

December 29, 2009

Nov 19, 2009 (SmarTrend(R) Spotlight via COMTEX) -- ARQL | Quote | Chart | News | PowerRating -- SmarTrend, our proprietary pattern recognition system, called a Downtrend for Arqule (NASDAQ:ARQL) on September 18, 2009 at $5.22.Since then, Arqule has returned 35.1% as of todays recent price o Read More >>

ArQule Presents Data at AACR-NCI-EORTC Conference

December 29, 2009

Nov 18, 2009 (Close-Up Media via COMTEX) -- ARQL | Quote | Chart | News | PowerRating -- ArQule, Inc. said that it has presented data at the AACR-NCI-EORTC meeting in Boston demonstrating the capabilities of the Companys proprietary drug discovery platform to generate a class of small molecu Read More >>

BiomedReports: News and FDA Updates for Acorda (Nasdaq:ACOR), Agilent (NYSE:A), ArQule (Nasdaq:ARQL)

December 29, 2009

Pasadena, CA, Nov 17, 2009 (M2 PRESSWIRE via COMTEX) -- ARQL | Quote | Chart | News | PowerRating -- BioMedReports.Com, the news portal which covers Wall Streets biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare st Read More >>

Drug Discovery Capabilities of ArQule Kinase Inhibitor Platform Presented at AACR-NCI-EORTC Conference

December 29, 2009

ArQule to Present at Lazard Capital Markets Annual Healthcare Conference

December 29, 2009

Nov 13, 2009 (Close-Up Media via COMTEX) -- ARQL | Quote | Chart | News | PowerRating -- ArQule, Inc. announced that it will present at the Lazard Capital Markets 6th Annual Healthcare Conference on Tuesday, November 17, at 5:10 p.m. eastern time.ArQules presentation will be web cast live an Read More >>

BiomedReports: News and FDA Updates for Akorn (NASDAQ:AKRX), Allos (NASDAQ:ALTH), ArQule (Nasdaq:ARQL)

December 29, 2009

Pasadena, CA, Nov 11, 2009 (M2 PRESSWIRE via COMTEX) -- ARQL | Quote | Chart | News | PowerRating -- BioMedReports.Com, the news portal which covers Wall Streets biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare st Read More >>

ArQule, Inc. to Present at Lazard Capital Markets Sixth Annual Healthcare Conference on November 17, 2009

December 29, 2009

ArQule Announces Third Quarter Fiscal 2009 Results

December 29, 2009

Arqule Down 35.4% Since SmarTrend's Sell Recommendation

December 29, 2009

Nov 01, 2009 (SmarTrend(R) Spotlight via COMTEX) -- ARQL | Quote | Chart | News | PowerRating -- SmarTrend, our proprietary pattern recognition system, called a Downtrend for Arqule (NASDAQ:ARQL) on September 18, 2009 at $5.22.Since then, Arqule has returned 35.4% as of Fridays recent price Read More >>

BiomedReports: News and FDA Updates for CVS (NYSE:CVS), VeriChip (NASDAQ:CHIP), ArQule (NASDAQ:ARQL)

December 29, 2009

Pasadena, CA, Oct 30, 2009 (M2 PRESSWIRE via COMTEX) -- CHIP | Quote | Chart | News | PowerRating -- BioMedReports.Com, the news portal which covers Wall Streets biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare st Read More >>

BiomedReports: News and FDA Updates for NPS (Nasdaq:NPSP), NeoPharm (OTC:NEOL), ArQule (NASDAQ:ARQL), Phase Forward (NASDAQ:PFWD

December 29, 2009

Pasadena, CA, Oct 30, 2009 (M2 PRESSWIRE via COMTEX) -- PFWD | Quote | Chart | News | PowerRating -- BioMedReports.Com, the news portal which covers Wall Streets biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare st Read More >>

ArQule, Inc. to Report Third Quarter 2009 Financial Results on Thursday, November 5, 2009

December 29, 2009

ArQule, Inc. to Present at Oppenheimer 20th Annual Healthcare Conference on November 3, 2009

December 29, 2009

EMEA Awards Orphan Drug Designation to ARQ 197 for Treatment of Soft Tissue Sarcoma

December 29, 2009

Oct 21, 2009 (Close-Up Media via COMTEX) -- ARQL | Quote | Chart | News | PowerRating -- ArQule, Inc. has announced that the European Medicines Evaluation Agency (EMEA) has designated ARQ 197 as an orphan medical product for the treatment of soft tissue sarcoma.Under the guidelines of the EME Read More >>

Arqule Down 24.3% Since SmarTrend's Sell Recommendation

December 29, 2009

Oct 20, 2009 (SmarTrend(R) Spotlight via COMTEX) -- ARQL | Quote | Chart | News | PowerRating -- SmarTrend, our proprietary pattern recognition system, called a Downtrend for Arqule (NASDAQ:ARQL) on September 18, 2009 at $5.22.Since then, Arqule has returned 24.3% as of todays recent price o Read More >>

Markettelegraph.com: Markettelegraph.com Profiles HearAtLast Holdings, Inc. & ArQule, Inc.

December 29, 2009

Boston, MA, Oct 15, 2009 (M2 PRESSWIRE via COMTEX) -- HRAL | Quote | Chart | News | PowerRating -- HearAtLast Holdings, Inc. (PINKSHEETS: HRAL); ArQule, Inc. (Nasdaq: ARQL)MarketTelegraph.com is part of Stock Profiler.US, LLCs News Division. Stock Profiler welcomes investors to sign up at ww Read More >>

ArQule to Introduce Novel FGFR Inhibitor Program Discovered Through Its Proprietary Kinase Inhibitor Platform at AACR-NCI-EORTC

December 29, 2009

European Medicines Evaluation Agency Grants Orphan Drug Designation to ARQ 197 for Treatment of Soft Tissue Sarcoma

December 29, 2009

ArQule (ARQL) Upgrade Alert, Watch for 21.1% Technical Downtrend Reversal

December 29, 2009

Oct 13, 2009 (SmarTrend(R) Spotlight via COMTEX) -- ARQL | Quote | Chart | News | PowerRating -- ArQule (NASDAQ:ARQL) upgraded to Buy from Neutral at UBS. The stock closed yesterday at $4.12 on volume of 184,000 shares, below average daily volume of 245,852.Arqule is currently below its 50-d Read More >>

Analyst Upgrades for October 13th

December 29, 2009

Oct 13, 2009 (SmarTrend(R) Upgrades/Downgrades via COMTEX) -- VFC | Quote | Chart | News | PowerRating -- Analyst Upgrades for 10/13/2009... ArQule (NASDAQ:ARQL) upgraded to Buy from Neutral at UBS... Citigroup (NYSE:C) initiated as Buy at Deutsche Bank... Cypress Semi (NYSE:CY) upgraded to H Read More >>

Arqule Down 19.5% Since SmarTrend's Sell Recommendation

December 29, 2009

Oct 07, 2009 (SmarTrend(R) Spotlight via COMTEX) -- ARQL | Quote | Chart | News | PowerRating -- SmarTrend, our proprietary pattern recognition system, called a Downtrend for Arqule (NASDAQ:ARQL) on September 18, 2009 at $5.22.Since then, Arqule has returned 19.5% as of todays recent price o Read More >>

StockPreacher.com Issues Trading Overview for Oncolytics Biotech Inc.

December 29, 2009

DALLAS, Oct 7, 2009 (GlobeNewswire via COMTEX) -- SUPG | Quote | Chart | News | PowerRating -- StockPreacher.com announces an investment report featuring Oncolytics Biotech Inc. (Nasdaq:ONCY). The report includes financial and investment analysis, analyst consensus, and pertinent industry inf Read More >>

ArQule Provides Clinical Update on ARQ 197

December 29, 2009

Arqule Down 13% Since SmarTrend's Sell Recommendation

December 29, 2009

Oct 01, 2009 (SmarTrend(R) Spotlight via COMTEX) -- ARQL | Quote | Chart | News | PowerRating -- SmarTrend, our proprietary pattern recognition system, called a Downtrend for Arqule (NASDAQ:ARQL) on September 18, 2009 at $5.22.Since then, Arqule has returned 13% as of todays recent price of Read More >>

Arqule Down 4% Since SmarTrend's Sell Recommendation

December 29, 2009

Sep 24, 2009 (SmarTrend(R) Spotlight via COMTEX) -- ARQL | Quote | Chart | News | PowerRating -- SmarTrend, our proprietary pattern recognition system, called a Downtrend for Arqule (NASDAQ:ARQL) on September 18, 2009 at $5.22.Since then, Arqule has returned 4% as of todays recent price of $ Read More >>

ArQule to Present at UBS Global Life Sciences Conference

December 29, 2009

Sep 16, 2009 (Close-Up Media via COMTEX) -- GFSC | Quote | Chart | News | PowerRating -- ArQule, Inc. announced that it will present at the UBS Global Life Sciences Conference on Monday, September 21, at 10:30 a.m. eastern time.ArQules presentation will be web cast live and can be accessed t Read More >>

UPCOMING EVENTS

Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.

Thursday March 25 04:30 PM

The TradingMarkets Swing Trading College Presentation

Thursday March 25 12:30 PM

Hear What Kevin Haggerty Sees in the Stock Market Today!

Wednesday March 24 01:00 PM

Hear What Gary Kaltbaum Sees in the Stock Market Today!

* Attendance is strictly limited and are filled on a first-come, first-served basis.

Free newsletters by the TradingMarkets editorial team.

Morning Coffee with TradingMarkets
Larry Connors Trading Lesson of the Day
7 Stocks You Need To Know For Tomorrow
TradingMarkets Weekly Newsletter
PowerRatings Newsletter
Most Overbought and Oversold ETFs
7 ETF's You Need to Know

PREMIER SPONSORED LINKS

TRADE CENTER

Recent Articles Market Analysis Stock Alerts Breaking News All News

About TradingMarkets Advertise Contact Careers Link to Us Help Terms & Conditions Privacy Policy Return Policy Testimonials Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.